» Articles » PMID: 35501614

A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption

Overview
Journal AAPS J
Specialty Pharmacology
Date 2022 May 2
PMID 35501614
Authors
Affiliations
Soon will be listed here.
Abstract

Traditionally, excipients have been considered in drug development from the perspective of their influence on drug solubility, manufacturability, and ability to control in vitro and in vivo drug release. These effects have been largely evaluated through studies involving in vitro dissolution methods. However, there is a growing awareness that what had previously been considered biologically inert excipients can exert numerous in vivo effects. This includes the potential to change gastrointestinal (GI) transit time, enterocyte passive transcellular or paracellular permeability, active transport activity, or presystemic drug metabolism. In this critical overview of the biological effects of excipients (Part I), we provide a summary of select published studies that explore these various in vivo factors. We also include a table that points readers to published reviews that list a range of excipients known to have biological activity. A subsequent discussion on in vitro, in vivo, and in silico methods that can be used to explore these excipient effects is provided in a separate (Part 2) continuation of this critical overview.

Citing Articles

In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug.

Gonzalez-Alvarez I, Ruiz-Picazo A, Selles-Talavera R, Figueroa-Campos A, Merino V, Bermejo M Pharmaceutics. 2024; 16(3).

PMID: 38543284 PMC: 10974868. DOI: 10.3390/pharmaceutics16030390.


The Necessity to Investigate In Vivo Fate of Nanoparticle-Loaded Dissolving Microneedles.

Chang Z, Wu Y, Hu P, Jiang J, Quan G, Wu C Pharmaceutics. 2024; 16(2).

PMID: 38399340 PMC: 10892231. DOI: 10.3390/pharmaceutics16020286.

References
1.
Irwin J, Pottel J, Zou L, Wen H, Zuk S, Zhang X . A Molecular Basis for Innovation in Drug Excipients. Clin Pharmacol Ther. 2016; 101(3):320-323. DOI: 10.1002/cpt.458. View

2.
Zhang W, Li Y, Zou P, Wu M, Zhang Z, Zhang T . The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update. AAPS J. 2016; 18(4):830-43. DOI: 10.1208/s12248-016-9928-8. View

3.
Fine-Shamir N, Beig A, Zur M, Lindley D, Miller J, Dahan A . Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer. Mol Pharm. 2017; 14(6):2138-2146. DOI: 10.1021/acs.molpharmaceut.7b00275. View

4.
Cox F, Khalib K, Conlon N . PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol. J Clin Pharmacol. 2021; 61(6):832-835. PMC: 8014770. DOI: 10.1002/jcph.1824. View

5.
Sjogren E, Abrahamsson B, Augustijns P, Becker D, Bolger M, Brewster M . In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. Eur J Pharm Sci. 2014; 57:99-151. DOI: 10.1016/j.ejps.2014.02.010. View